It is suggested that TREM2 exerts a pro-proliferative effect on thyroid cancer cells by activating the NF-κB signaling pathway to upregulate the expression of cyclin D1 and Bcl2, indicating that TREM2 may be located upstream of the NF-κB signaling pathway. This evidence concerns the gene BCL2 and thyroid cancer.